Federal contract award

75N91022F00001

NATIONAL CHILDHOOD CANCER REGISTRY (NCCR)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS813920 — Professional Organizations
PSCB529 — Scientific Data Studies
Parent award / vehicle75N91021D00018
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$4.2M
Current contract value$4.2M
Potential contract value / ceiling$4.8M
Start dateJul 1, 2022
Current end dateAug 31, 2026
Potential end dateAug 31, 2026
Latest award activityJun 29, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 29, 2026P00011$146.5K1) EXERCISE FAR 52.217-8, EXTENDING POP 7/1/26-08/31/26; 2) OBLIGATE FY26 FUNDS; 3) UPDATE ARTICLES B.2, B.3, F.1, G.4.
Sep 23, 2025P00010$01) DESCOPE SOW FOR TERM OPT PD 3, DECREASE ITS NEGOTIATED COST AND THE CONTRACT TOTAL DUE TO EOI:: IMPLEMENTING THE PRESIDENTS DEPART OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI; 2) UPDATED ARTS B.3.D, B.2, C.1, SECT J.1
Jun 27, 2025P00009$637.3KNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Dec 9, 2024P00008$0NATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Sep 9, 2024P00007$176.9KNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Jun 25, 2024P00006$1.0MNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Sep 11, 2023P00005$295.0KNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Jul 27, 2023P00004$0NATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Jun 27, 2023P00003$884.6KNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Apr 28, 2023P00002$115.4KNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Feb 22, 2023P00001$0NATIONAL CHILDHOOD CANCER REGISTRY (NCCR)
Jun 29, 20220$976.0KNATIONAL CHILDHOOD CANCER REGISTRY (NCCR)

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.